Contour Venture Partners

About

Portfolio · 3

Rylo

Text and Speech Conversion

1 round $11.0M committed Latest: 2024-07

WaveBL

Digital Document Courier Solution

2 rounds $37.0M committed Latest: 2024-01

Leal Health

AI-based Decision Support Platform for Cancer Treatment

Led ★ 3 rounds $27.7M committed Latest: 2022-02

Investment activity

1 portfolio exit on record.

Funds · 1

• 5 — $42M May 2024

Q&A

What is Contour Venture Partners' primary investment focus?

Contour Venture Partners is an early-stage venture capital firm based in New York, focusing on companies that provide leading-edge technology-enhanced products and services in the financial services, internet, and business services sectors.

Which stages does Contour Venture Partners typically invest in?

Contour Venture Partners invests in Seed, A Round, and Pre-Seed stages.

Can you name some of Contour Venture Partners' notable portfolio companies?

Contour Venture Partners' portfolio includes Leal Health, an AI-based decision support platform for cancer treatment, and Nagish, which focuses on text and speech conversion.

Has Contour Venture Partners had any recent exits?

Yes, Leal Health, a portfolio company, was acquired by Nexus Precision Health in February 2026.

What is the most recent fund raised by Contour Venture Partners?

Contour Venture Partners raised Fund 5, amounting to $42M, in May 2024.

Who are the key people at Contour Venture Partners?

The key team members at Contour Venture Partners include Matt Gorin, Co-founder & Managing Partner, Bob Greene, Managing Partner, and Owen Davis, General Partner.

What is Contour Venture Partners' investment range?

Contour Venture Partners' investment range is between $2.7M and $26M.

Which sectors has Contour Venture Partners shown concentration in for its investment rounds?

Contour Venture Partners has shown concentration in Health Tech & Life Sciences, Fintech & Insurtech, and Media & Entertainment Technologies for its investment rounds.